want to
join our members?
Access your business needs with Amcham Finland in a 15-minute call.
June 9
Online
Wednesday, May 19
Online
Monday, May 10
Online
Wednesday, April 28
Online
On January 30, the EU established a “transparency and authorization mechanism” for vaccine exports prohibiting the export of Covid-19 vaccines to select destinations outside the EU without prior approval. Amcham has published a statement regarding our concerns towards restricting exports because it may lead to vaccine spoilage and delay the resolution of the current public health crisis.
Thursday, Feb 11
Online
Now that Joe Biden is U.S. President-elect, we anticipate that some of the existing business-immigration roadblocks may dissolve. Practically speaking, however, implementation of more favorable rules will take time. In addition, lockdowns and limited resources due to a new wave of Covid-19 will continue to cause immigration delays, at least for the time being.
It is anticipated that President-elect Biden will immediately implement executive orders undermining President Trump’s policies related to immigration, climate change and management of Covid-19. It is also expected that the Biden-Kamala team will dedicate substantially more attention to data privacy which is significant to international data transfers, particularly in light of the July 2020 Schrems II decision invalidating the EU-US Privacy Shield due to US surveillance concerns.
Deb Mangone recently became Pfizer Finland’s new Country Manager. She arrived from New York City, and we interviewed her to learn what motivated her decision to come here. How does she perceive Finland’s strengths and weaknesses as a business environment and home?
Access your business needs with Amcham Finland in a 15-minute call.